Researchers at King's College London have developed IgE antibodies targeting HER2-expressing cancers. Early studies show ...

Combinations of rhinitis, asthma, and IgE captured information on disease pathophysiology. Results: Omalizumab is a monoclonal antibody targeting the high-affinity receptor binding site on human ...

A new anti-HER2 IgE antibody potentially offers new therapy options for treatment-resistant breast and ovarian cancers.

WATERTOWN, Mass.--(BUSINESS WIRE)--Seismic Therapeutic, Inc., the machine learning immunology company, today announced the presentation of preclinical data for its immunoglobulin E (IgE) protease ...

In vitro, omalizumab and human IgE form several immune complexes that vary in size as the 2 components' molar ratios are changed. [29] The largest complex, a stable cyclical hexameric structure ...